MedCity News April 29, 2025
Hims & Hers is now offering discounted access to Wegovy, a GLP-1 manufactured by Novo Nordisk, on its platform.
Pharmaceutical company Novo Nordisk is teaming up with direct-to-consumer telehealth company Hims & Hers to offer discounted access to Wegovy, a GLP-1 manufactured by Novo Nordisk, the companies announced on Tuesday.
Hims & Hers provides treatments for weight, anxiety, sexual health and other conditions. Through the partnership, consumers can now access NovoCare Pharmacy, Novo Nordisk’s direct-to-consumer delivery option, directly through the Hims & Hers platform. Starting at $599 a month, consumers can be prescribed Wegovy and receive a Hims & Hers membership. The latter includes 24/7 care, clinical support and nutrition guidance.
Before the partnership, the cost of Wegovy on...
Today's Sponsors
Today's Sponsor